"Survival Gains from Advances in First-line Systemic Therapy for HER2-positive Metastatic Breast Cancer in the U.S., 1995-2015" by Reshma Mahtani

Article

Survival Gains from Advances in First-line Systemic Therapy for HER2-positive Metastatic Breast Cancer in the U.S., 1995-2015

Annals of Oncology / 39th European Society for Medical Oncology. ESMO Congress (2018)

Reshma Mahtani, Baptist Health South Florida
J. Roth
S. Sullivan
C. Reyes
V. Antao
A. Stein
S. Ramsey

Link

Disciplines

Medicine and Health Sciences

Publication Date

2018

Citation Information

Reshma Mahtani, J. Roth, S. Sullivan, C. Reyes, et al.. "Survival Gains from Advances in First-line Systemic Therapy for HER2-positive Metastatic Breast Cancer in the U.S., 1995-2015" Annals of Oncology / 39th European Society for Medical Oncology. ESMO Congress Vol. 29 Iss. suppl. 8 (2018) p. viii90 - viii121
Available at: http://works.bepress.com/reshma-mahtani/16/